Sign up
Pharma Capital

Callitas Health names James Thompson president and CEO of the health and wellness company

Thomspon has been serving as interim chief after Gary Thompson stepped down for health reasons
Medicinal marijuana
Callitas recently welcomed a new chief medical cannabis advisor

Callitas Health Inc (CSE:LILY, OTCQB:MPHMF) announced that its interim CEO, James Thompson, will now be a permanent fixture at the head of the health and wellness company.

Thompson was also serving as interim president after former CEO Gary Thompson stepped down for health reasons. The new CEO was formerly the company’s chief operating officer before stepping up to fill the void.

READ: Callitas Health bolsters cannabis products business by hiring industry expert as advisor

“We look forward to where and how he expands the products and offerings of the company. He is a strong business leader and the right fit for Callitas as the company reaches new levels of expansion," said board member William Rodgers.

Callitas recently welcomed Dr. Gregory Smith, a medical expert well-versed in cannabinoid medication, as the firm’s chief medical cannabis advisor.

One of the clinical-stage company’s newest products included CannaMint Strips, a minty breath strip that offers users a discreet way to use cannabis.

Shares of the Ohio-based company were flat at US$0.18 in Thursday pre-market trading.

View full LILY profile View Profile
View All

Related Articles

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.